• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    Radial Artery Compression Devices Market

    ID: MRFR/HC/6543-HCR
    100 Pages
    Rahul Gotadki
    October 2025

    Radial Artery Compression Devices Market Research Report Information by Product (Band/Strap Based Devices, Knob-Based Devices, Plate-Based Devices), Usage (Disposable Devices, Reusable Devices) and End User (Hospitals, Clinics, Ambulatory Centers, Cath Lab) - Forecast till 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Radial Artery Compression Devices Market Infographic
    Purchase Options

    Radial Artery Compression Devices Market Summary

    As per Market Research Future Analysis, the Radial Artery Compression Devices Market was valued at USD 0.58 Billion in 2024 and is projected to grow to USD 1.36 Billion by 2035, with a CAGR of 8.05% from 2025 to 2035. The market is driven by increasing cardiovascular disorders, technological advancements, and a growing geriatric population. Key developments include Terumo Medical's new manufacturing facility in Puerto Rico and the introduction of innovative devices like TZ Medical's Roc Band and Merit Medical's PreludeSYNC EZ. The market is segmented by product, usage, and end user, with significant growth expected across all segments.

    Key Market Trends & Highlights

    The Radial Artery Compression Devices Market is witnessing significant advancements and growth driven by various factors.

    • Market Size in 2024: USD 0.58 Billion; projected to reach USD 1.36 Billion by 2035.
    • CAGR of 8.05% during the forecast period (2024 - 2032).
    • Major growth factors include increasing cardiovascular disorders and technological advancements in medical devices.
    • Americas expected to dominate the market due to high healthcare expenditure and patient population.

    Market Size & Forecast

    2024 Market Size USD 0.58 Billion
    2035 Market Size USD 1.36 Billion
    CAGR 8.05%

    Major Players

    Terumo Corporation, Merit Medical, Inc., Medtronic, Abbott Laboratories, Vascular Solution, Inc.

    Radial Artery Compression Devices Market Drivers

    Market Growth Projections

    The Global Radial Artery Compression Devices Market Industry is projected to experience substantial growth, with estimates indicating a rise from 0.58 USD Billion in 2024 to 1.34 USD Billion by 2035. This growth trajectory reflects a compound annual growth rate (CAGR) of 7.89% from 2025 to 2035. Such projections highlight the increasing reliance on radial artery access in various medical procedures, driven by technological advancements and a growing patient population. The market's expansion is indicative of the broader trends in healthcare, where efficiency, safety, and patient satisfaction are becoming increasingly prioritized.

    Regulatory Support and Guidelines

    Regulatory bodies are increasingly recognizing the importance of radial artery compression devices, which positively impacts the Global Radial Artery Compression Devices Market Industry. Guidelines that endorse the use of these devices in clinical settings enhance their credibility and encourage adoption among healthcare providers. Such support from regulatory agencies may lead to a more structured approach to device implementation, ensuring that safety and efficacy standards are met. This regulatory backing is likely to stimulate market growth, as healthcare facilities seek to comply with best practices and improve patient care.

    Rising Incidence of Cardiovascular Diseases

    The Global Radial Artery Compression Devices Market Industry is significantly influenced by the increasing prevalence of cardiovascular diseases worldwide. As these conditions become more common, the demand for effective diagnostic and therapeutic interventions rises correspondingly. Radial artery access is often preferred for procedures such as angioplasty, which further drives the need for reliable compression devices. With the market expected to grow at a CAGR of 7.89% from 2025 to 2035, this trend underscores the urgency for healthcare systems to adopt advanced solutions that can effectively address the growing burden of cardiovascular health issues.

    Technological Advancements in Device Design

    Technological innovations play a pivotal role in the Global Radial Artery Compression Devices Market Industry. Enhanced device designs, such as automated compression systems and user-friendly interfaces, improve the efficacy and safety of procedures. These advancements not only streamline the application process but also minimize complications associated with traditional methods. As a result, healthcare professionals are more inclined to utilize these devices, contributing to a projected market growth to 1.34 USD Billion by 2035. The integration of smart technology into these devices may further enhance their appeal, suggesting a promising trajectory for future developments.

    Increasing Demand for Minimally Invasive Procedures

    The Global Radial Artery Compression Devices Market Industry experiences heightened demand due to the growing preference for minimally invasive procedures. These devices facilitate quicker recovery times and reduced patient discomfort, which are critical factors in modern healthcare. As healthcare providers increasingly adopt these techniques, the market is projected to reach 0.58 USD Billion in 2024. This trend aligns with a broader shift towards patient-centric care, where efficiency and safety are paramount. The adoption of radial artery access for various cardiovascular interventions exemplifies this movement, indicating a robust future for radial artery compression devices.

    Growing Awareness and Training Among Healthcare Professionals

    The Global Radial Artery Compression Devices Market Industry benefits from increased awareness and training among healthcare professionals regarding the advantages of radial access techniques. Educational initiatives and workshops are being implemented to enhance the skills of medical personnel, thereby promoting the adoption of these devices. As practitioners become more knowledgeable about the benefits of radial artery compression, the likelihood of incorporating these devices into standard practice increases. This trend not only supports market growth but also contributes to improved patient outcomes, suggesting a synergistic relationship between education and device utilization.

    Key Companies in the Radial Artery Compression Devices Market market include

    Industry Developments

    • Q2 2024: Terumo Launches New Radial Artery Compression Device 'TR Band Plus' in Europe Terumo Corporation announced the commercial launch of its next-generation radial artery compression device, the 'TR Band Plus', in select European markets, aiming to improve patient comfort and hemostasis after transradial procedures.
    • Q1 2024: Merit Medical Receives CE Mark for PreludeSYNC EVO Radial Compression Device Merit Medical Systems announced it has received CE Mark approval for its PreludeSYNC EVO, a new radial artery compression device designed to enhance safety and ease of use for vascular access site management.
    • Q3 2024: Abbott Launches Radial Artery Compression Device in Asia-Pacific Abbott Laboratories announced the launch of its latest radial artery compression device in the Asia-Pacific region, expanding its cardiovascular product portfolio and targeting growing demand for minimally invasive cardiac procedures.
    • Q2 2024: Teleflex Announces FDA Clearance for New Radial Compression Device Teleflex Incorporated received FDA clearance for its new radial artery compression device, enabling U.S. commercialization and supporting the company's strategy to expand its interventional cardiology offerings.
    • Q1 2025: Boston Scientific Acquires Start-Up Specializing in Radial Artery Compression Technology Boston Scientific announced the acquisition of a medical device start-up focused on innovative radial artery compression technology, aiming to strengthen its position in the vascular access management market.
    • Q2 2025: Cardinal Health Opens New Manufacturing Facility for Radial Compression Devices in Texas Cardinal Health inaugurated a new manufacturing facility in Texas dedicated to the production of radial artery compression devices, increasing its capacity to meet rising demand in North America.
    • Q3 2024: Medtronic Announces Strategic Partnership with Leading Hospital Network for Radial Compression Device Trials Medtronic plc entered into a strategic partnership with a major U.S. hospital network to conduct clinical trials of its next-generation radial artery compression device, aiming for broader clinical adoption.
    • Q4 2024: Advanced Vascular Dynamics Receives Health Canada Approval for Radial Compression Device Advanced Vascular Dynamics announced it has received Health Canada approval for its flagship radial artery compression device, allowing for immediate commercialization in the Canadian market.
    • Q2 2025: BD Launches Next-Generation Radial Artery Compression Device in Europe BD announced the European launch of its next-generation radial artery compression device, featuring enhanced ergonomic design and antimicrobial properties to reduce infection risk.
    • Q1 2025: Vascular Solutions Wins Major Supply Contract for Radial Compression Devices with National Health System Vascular Solutions, Inc. secured a multi-year supply contract to provide its radial artery compression devices to a national health system, significantly expanding its market presence.
    • Q4 2024: Terumo Appoints New Head of Global Vascular Access Division Terumo Corporation announced the appointment of a new executive to lead its Global Vascular Access Division, reflecting the company's commitment to innovation and growth in the radial artery compression device sector.
    • Q3 2025: Abbott Receives FDA Approval for Next-Gen Radial Compression Device Abbott Laboratories received FDA approval for its next-generation radial artery compression device, enabling U.S. launch and supporting its expansion in the interventional cardiology market.

    Future Outlook

    Radial Artery Compression Devices Market Future Outlook

    The Radial Artery Compression Devices Market is projected to grow at a 8.05% CAGR from 2025 to 2035, driven by technological advancements, increasing cardiovascular procedures, and rising demand for minimally invasive surgeries.

    New opportunities lie in:

    • Develop smart compression devices integrating IoT for real-time monitoring.
    • Expand product lines to include customizable compression settings for diverse patient needs.
    • Leverage partnerships with hospitals to enhance distribution and training on device usage.

    By 2035, the Radial Artery Compression Devices Market is expected to achieve substantial growth, reflecting evolving healthcare demands.

    Market Segmentation

    Key Players

    • Beijing Demax Medical Technology
    • Comed B.V.
    • Advanced Vascular Dynamics
    • Vascular Solution, Inc.
    • Abbott Laboratories
    • MEDAS INC
    • HTKD Medical
    • Perouse Medical
    • ADVANCED LIFESCIENCES PVT. LTD
    • Medtronic
    • Merit Medical, Inc.
    • Terumo Corporation

    Intended Audience

    • Various research and consulting firms
    • Government agencies
    • Private insurance companies
    • Hospitals, clinics, and associations
    • Radial artery compression devices distributors
    • Radial artery compression devices manufacturers

    Market of Radial Artery Compression Devices, by Usage

    • Reusable Devices
    • Disposable Devices

    Radial Artery Compression Devices Market Segmentation

    • Beijing Demax Medical Technology
    • Comed B.V.
    • Advanced Vascular Dynamics
    • Vascular Solution, Inc.
    • Abbott Laboratories
    • MEDAS INC
    • HTKD Medical
    • Perouse Medical
    • ADVANCED LIFESCIENCES PVT. LTD
    • Medtronic
    • Merit Medical, Inc.
    • Terumo Corporation

    Market of Radial Artery Compression Devices, by Region

    • South America
    • Canada
    • US
    • North America
    • Americas
    • Eastern Europe
    • Rest of Western Europe
    • UK
    • Spain
    • Italy
    • France
    • Germany
    • Western Europe
    • Europe
    • Rest of Asia-Pacific
    • South Korea
    • Australia
    • India
    • China
    • Japan
    • Asia-Pacific
    • Africa
    • Middle East
    • Middle East & Africa
    • Various research and consulting firms
    • Government agencies
    • Private insurance companies
    • Hospitals, clinics, and associations
    • Radial artery compression devices distributors
    • Radial artery compression devices manufacturers

    Market of Radial Artery Compression Devices, by Product

    • Others
    • Plate-Based Devices
    • Knob-Based Devices
    • Band/Strap Based Devices

    Market of Radial Artery Compression Devices, by End User

    • Others
    • Cath lab
    • Ambulatory Centers
    • Clinics
    • Hospitals

    Radial Artery Compression Devices Market Industry Developments

    • Q2 2024: Terumo Launches New Radial Artery Compression Device 'TR Band Plus' in Europe Terumo Corporation announced the commercial launch of its next-generation radial artery compression device, the 'TR Band Plus', in select European markets, aiming to improve patient comfort and hemostasis after transradial procedures.
    • Q1 2024: Merit Medical Receives CE Mark for PreludeSYNC EVO Radial Compression Device Merit Medical Systems announced it has received CE Mark approval for its PreludeSYNC EVO, a new radial artery compression device designed to enhance safety and ease of use for vascular access site management.
    • Q3 2024: Abbott Launches Radial Artery Compression Device in Asia-Pacific Abbott Laboratories announced the launch of its latest radial artery compression device in the Asia-Pacific region, expanding its cardiovascular product portfolio and targeting growing demand for minimally invasive cardiac procedures.
    • Q2 2024: Teleflex Announces FDA Clearance for New Radial Compression Device Teleflex Incorporated received FDA clearance for its new radial artery compression device, enabling U.S. commercialization and supporting the company's strategy to expand its interventional cardiology offerings.
    • Q1 2025: Boston Scientific Acquires Start-Up Specializing in Radial Artery Compression Technology Boston Scientific announced the acquisition of a medical device start-up focused on innovative radial artery compression technology, aiming to strengthen its position in the vascular access management market.
    • Q2 2025: Cardinal Health Opens New Manufacturing Facility for Radial Compression Devices in Texas Cardinal Health inaugurated a new manufacturing facility in Texas dedicated to the production of radial artery compression devices, increasing its capacity to meet rising demand in North America.
    • Q3 2024: Medtronic Announces Strategic Partnership with Leading Hospital Network for Radial Compression Device Trials Medtronic plc entered into a strategic partnership with a major U.S. hospital network to conduct clinical trials of its next-generation radial artery compression device, aiming for broader clinical adoption.
    • Q4 2024: Advanced Vascular Dynamics Receives Health Canada Approval for Radial Compression Device Advanced Vascular Dynamics announced it has received Health Canada approval for its flagship radial artery compression device, allowing for immediate commercialization in the Canadian market.
    • Q2 2025: BD Launches Next-Generation Radial Artery Compression Device in Europe BD announced the European launch of its next-generation radial artery compression device, featuring enhanced ergonomic design and antimicrobial properties to reduce infection risk.
    • Q1 2025: Vascular Solutions Wins Major Supply Contract for Radial Compression Devices with National Health System Vascular Solutions, Inc. secured a multi-year supply contract to provide its radial artery compression devices to a national health system, significantly expanding its market presence.
    • Q4 2024: Terumo Appoints New Head of Global Vascular Access Division Terumo Corporation announced the appointment of a new executive to lead its Global Vascular Access Division, reflecting the company's commitment to innovation and growth in the radial artery compression device sector.
    • Q3 2025: Abbott Receives FDA Approval for Next-Gen Radial Compression Device Abbott Laboratories received FDA approval for its next-generation radial artery compression device, enabling U.S. launch and supporting its expansion in the interventional cardiology market.

    Report Scope

    Report Attribute/Metric Details
    Market Size 2024 USD 0.58 Billion
    Market Size 2035 1.36 (Value (USD Billion))
    Compound Annual Growth Rate (CAGR) 8.05% (2025 - 2035)
    Base Year 2024
    Market Forecast Period 2025 - 2035
    Historical Data 2018- 2022
    Market Forecast Units Value (USD Billion)
    Report Coverage Market Competitive Landscape, Growth Factors, Revenue Forecast, and Trends
    Segments Covered Product and End-User
    Geographies Covered North America, Europe, Asia Pacific, and the Rest of the World
    Countries Covered US, Canada, France, German, Italy, UK, Spain, Japan, China, Australia, India, South Korea, and Brazil.
    Key Companies Profiled Comed B.V., Advanced Vascular Dynamics, Beijing Demax Medical Technology, Vascular Solution Inc., MEDAS INC, HTKD Medical, Perouse Medical, ADVANCED LIFESCIENCES PVT. LTD, Abbott Laboratories, Merit Medical, Inc., Medtronic, and Terumo Corporation.
    Market Size 2025 0.63 (Value (USD Billion))

    Market Highlights

    Author
    Rahul Gotadki
    Assistant Manager

    He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

    Leave a Comment

    FAQs

    What is the projected growth of the Radial Artery Compression Devices market?

    The Radial Artery Compression Devices market is the expected increase in total market value of 1.36 USD billion over a defined forecast period 2025–2035. It is driven by factors such as demand trends, technological advances, regulatory changes, and geographic expansion.

    What is the size of the Radial Artery Compression Devices market?

    Radial Artery Compression Devices market size was valued at approximately 0.58 billion USD in 2024. This figure will reach 1.36 billion USD covering all regions (America, Europe, Asia, MEA and ROW), focusing its segments / services / distribution channels till 2035.

    What is the CAGR of the Radial Artery Compression Devices market?

    Radial Artery Compression Devices market is expected to grow at a CAGR of 8.05% between 2025 and 2035.

    How much will the Radial Artery Compression Devices market be worth by 2035?

    Radial Artery Compression Devices market is expected to be worth of 1.36 billion USD, reflecting growth driven by usage, technology and global demands by the end of 2035.

    How will the Radial Artery Compression Devices market perform over the next 10 years?

    Over the next 10 years the Radial Artery Compression Devices market is expected to shift from usd billion 0.58 to 1.36 billion USD, led by adoption of advanced tech, demographic trends, regulatory approvals, with potential headwinds from 2025 to 2035.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials